Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Test Type
3.2. Snippet by End User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The high prevalence of cardiovascular diseases is expected to drive the market
4.1.1.2. Technological advancements in heart attack diagnostics devices
4.1.2. Restraints
4.1.2.1. Lack of skilled workforce will hamper the market growth
4.1.3. Opportunity
4.1.3.1. The development of more sophisticated imaging techniques, such as cardiac MRI
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Epidemiology Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Artificial Intelligence Impact Analysis
9. By Test Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
9.1.2. Market Attractiveness Index, By Test Type
9.2. Electrocardiogram
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Blood Tests
9.4. Angiogram
9.5. Computerized Cardiac Tomography
9.6. Magnetic Resonance Imaging (MRI)
9.7. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.1.3. Hospitals
10.1.4. Introduction
10.1.5. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.2. Ambulatory Surgical Centers
10.3. Diagnostics Centers
10.4. Cardiac Centers
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.5.1. The U.S.
11.2.5.2. Canada
11.2.5.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.5.1. Germany
11.3.5.2. The U.K.
11.3.5.3. France
11.3.5.4. Italy
11.3.5.5. Spain
11.3.5.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.5.1. Brazil
11.4.5.2. Argentina
11.4.5.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.5.1. China
11.5.5.2. India
11.5.5.3. Japan
11.5.5.4. Australia
11.5.5.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. F Hoffmann-La Roche Ltd
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Hitachi Medical Systems
13.3. GE Healthcare
13.4. Schiller AG
13.5. Siemens Healthineers
13.6. HeartFlow
13.7. Beckman Coulter, Inc.
13.8. Medtronic
13.9. Cardio Diagnostics Holdings Inc
13.10. Midmark Corporation.
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us